Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets

(2018) Brendan Mulhern et al.   PHARMACOECONOMICS

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values

(2018) Anna Selivanova et al.   PHARMACOECONOMICS

3L, 5L, What the L? A NICE Conundrum

(2018) Nancy Devlin et al.   PHARMACOECONOMICS

German Value Set for the EQ-5D-5L

(2018) Kristina Ludwig et al.   PHARMACOECONOMICS

Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries

(2018) Mathieu F. Janssen et al.   PHARMACOECONOMICS

Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter

(2018) Zhihao Yang et al.   VALUE IN HEALTH

EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom

(2018) Monica Hernandez Alava et al.   VALUE IN HEALTH

Valuing health-related quality of life: An EQ-5D-5L value set for England

(2017) Nancy J. Devlin et al.   HEALTH ECONOMICS

Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis

(2017) Mónica Hernández-Alava et al.   JOURNAL OF HEALTH ECONOMICS

The Indonesian EQ-5D-5L Value Set

(2017) Fredrick Dermawan Purba et al.   PHARMACOECONOMICS

Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores

(2017) Nathan S. McClure et al.   VALUE IN HEALTH

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada

(2016) Feng Xie et al.   MEDICAL CARE

The EQ-5D-5L valuation study in Korea

(2016) Seon-Ha Kim et al.   QUALITY OF LIFE RESEARCH

An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies

(2016) Koonal Shah et al.   VALUE IN HEALTH

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan

(2016) Takeru Shiroiwa et al.   VALUE IN HEALTH

Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?

(2015) Yan Feng et al.   Health and Quality of Life Outcomes

An EQ-5D-5L value set based on Uruguayan population preferences

(2015) Federico Augustovski et al.   QUALITY OF LIFE RESEARCH

Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010

(2014) Torbjørn Wisløff et al.   PHARMACOECONOMICS

A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol

(2014) Mark Oppe et al.   VALUE IN HEALTH

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study

(2012) M. F. Janssen et al.   QUALITY OF LIFE RESEARCH

Learning Effects in Time Trade-Off Based Valuation of EQ-5D Health States

(2012) Liv Ariane Augestad et al.   VALUE IN HEALTH

Are Utilities Bounded at 1.0? Implications for Statistical Analysis and Scale Development

(2011) Patrick W. Sullivan   MEDICAL DECISION MAKING

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

(2011) M. Herdman et al.   QUALITY OF LIFE RESEARCH

Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?

(2010) Eleanor M. Pullenayegum et al.   VALUE IN HEALTH

QALYs: The Basics

(2009) Milton C. Weinstein et al.   VALUE IN HEALTH